Cartesian Therapeutics (RNAC) Institutional Ownership

$26.34
-0.31 (-1.16%)
(As of 05/16/2024 ET)

Institutional Ownership Changes (13F Filings) for Cartesian Therapeutics (NASDAQ:RNAC)

Current
Institutional Ownership
Percentage
86.95%
Number of
Institutional Buyers
(last 12 months)
6
Total
Institutional Inflows
(last 12 months)
$140.23M
Number of
Institutional Sellers
(last 12 months)
0
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

Skip Chart & View Institutional Buying and Selling Data

RNAC Institutional Buying and Selling by Quarter

Cartesian Therapeutics Major Shareholders & Ownership History

Reporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
5/14/2024 American International Group Inc.56,202$37K0.0%N/A1.052%
5/10/2024 Vanguard Group Inc.6,315,113$4.11M0.0%N/A118.172%
5/7/2024 SG Americas Securities LLC47,134$31K0.0%N/A0.883%
5/3/2024Delphi Financial Group Inc.660,852$430K0.3%N/A12.261%
5/1/2024 BNP Paribas Financial Markets59,125$38K0.0%N/A1.097%
4/23/2024 Hall Laurie J Trustee52,775$34K0.0%N/A0.979%
(Data available from 1/1/2016 forward)

RNAC Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of RNAC shares?

During the previous two years, the following institutional investors and hedge funds held shares of Cartesian Therapeutics shares: Vanguard Group Inc. ($4.11M), Delphi Financial Group Inc. ($430K), BNP Paribas Financial Markets ($38K), American International Group Inc. ($37K), and Hall Laurie J Trustee ($34K), SG Americas Securities LLC ($31K).Learn more on RNAC's institutional investors.

What percentage of Cartesian Therapeutics stock is owned by institutional investors?

86.95% of Cartesian Therapeutics stock is owned by institutional investors. Learn more on RNAC's institutional investor holdings.

Which institutional investors have been buying Cartesian Therapeutics stock?

The following institutional investors have purchased Cartesian Therapeutics stock in the last 24 months: Vanguard Group Inc. ($6.32M), Delphi Financial Group Inc. ($660.85K), BNP Paribas Financial Markets ($59.13K), American International Group Inc. ($56.20K), Hall Laurie J Trustee ($52.78K), and SG Americas Securities LLC ($47.13K).

How much institutional buying is happening at Cartesian Therapeutics?

Institutional investors have bought a total of 7,191,201 shares in the last 24 months. This purchase volume represents approximately $140.23M in transactions.


This page (NASDAQ:RNAC) was last updated on 5/17/2024 by MarketBeat.com Staff

From Our Partners